Keywords
diabetes mellitus, enzyme replacement therapy, pancreatic exocrine insufficiency, pathogenesis, steatorrhea
How to Cite
Zsóri, G., Illés, D., Terzin, V., & Czakó, L. (2019). Exocrine pancreatic insufficiency in type 1 and type 2 diabetesmellitus: do we need to treat it? A systematic review. Herald of Pancreatic Club, 42(1), 18-29. https://doi.org/10.33149/vkp.2019.01.03
Abstract views: 481 PDF Downloads: 670 PDF Downloads: 148
Abstract
The exocrine and endocrine pancreata are very closely linked both anatomically and physiologically. Abdominal symptoms such as nausea, bloating, diarrhea, steatorrhea, and weight loss can often occur in diabetic patients. Impairments of the exocrine pancreatic function seem to be a frequent complication of diabetes mellitus; however, they are largely overlooked. The aim of this paper is to provide an overview of the current concepts of exocrine pancreatic insufficiency (PEI) in diabetes mellitus. This systematic review provides information on the high prevalence of chronic pancreatic diseases in patients with diabetes; statements that reveal the multifactorial mechanism of PEI development upon violation of glucose uptake are summarized. The main PEI clinical manifestations in diabetes are described, the difficulties of timely detection of EPN are considered, the advantages and disadvantages of the “gold standards” of laboratory diagnostics (determination of the level of fecal elastase 1 and the coefficient of fat absorption, respiratory test using mixed triglycerides, 13C labeled, and secretin-pancreozymin test) in this cohort of patients. The data of randomized researches that studied the effectiveness of enzyme replacement therapy of PEI in patients with diabetes are analyzed. The ability of enzyme replacement therapy to normalize digestion has been confirmed, and its possible effect on glycemia and vitamin D levels in patients with diabetes and EPN has been considered. The reasons for the continuation of taking enzyme preparations are listed.
References
1. Altobelli E., Blasetti A., Verrotti A., Di Giandomenico V., Bonomo L., Chiarelli F. Size of pancreas in children and adolescents with type I (insulin-dependent) diabetes. J. Clin. Ultrasound. 1998. Vol. 26, No 8. P. 391–395.
2. Alzaid A., Aideyan O., Nawaz S. The size of the pancreas in diabetes mellitus. Diabet. Med. 1993. Vol. 10, No 8. P. 759–763.
3. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017. Vol. 40, No 1. P. 11– 24.
4. Barreto S. G., Carati C. J., Toouli J., et al. The islet-acinar axis of the pancreas: more than just insulin. Am. J. Physiol. Gastrointest. Liver Physiol. 2010. Vol. 299, No 1. P. 10–22.
5. Berry A. J. Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr. Clin. Pract. 2014. Vol. 29. P. 312–321.
6. Bilgin M., Balci N. C., Momtahen A. J., Bilgin Y., Klor H. U., Rau W. S. MRI and MRCP findings of the pancreas pancreatic exocrine function determined by fecal elastase 1. J. Clin. Gastroenterol. 2009. Vol. 43, No 2. P. 165–170.
7. Blumenthal H. T., Probstein J. G., Berns A. W. Interrelationship of diabetes mellitus and pancreatitis. Arch. Surg. 1963. Vol. 87. P. 844–850.
8. Bresnahan K. A., Tanumihardjo S. A. Undernutrition, the acute phase response to infection, and its effects on micronutrient status indicators. Adv. Nutr. 2014. Vol. 5, No 6. P. 702–711.
9. Bretzke G. Diabetes mellitus und exocrine pancreas function. Zeitschriftfur dieGesamteInnereMedizin und IhreGrenzgebiete. 1984. Vol. 39, No 16. P. 388–390.
10. Burute N., Nisenbaum R., Jenkins D. J., Mirrahimi A., Anthwal S., Colak E., et al. Pancreas volume measurement in patients with type 2 diabetes using magnetic resonance imaging-based planimetry. Pancreatology. 2014. Vol. 14, No 4. P. 268–274.
11. Cavalot F., Bonomo K., Perna P., Bacillo E., Salacone P., Gallo M., et al. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual ß-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care. 2004. Vol. 27, No 8. P. 2052–2054.
12. Chey W. Y., Shay H., Shuman C. R. External pancreatic secretion in diabetes mellitus. Ann. Intern. Med. 1953. Vol. 59. P. 812–821.
13. Creutzfeldt W., Gleichmann D., Otto J, Stockmann F., Maisonneuve P., Lankisch P. G. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion. 2005. Vol. 72. P. 71–75.
14. Cummings M. H, Chong L., Hunter V., Kar P. S., Meeking D. R., Cranston I. C. Gastrointestinal symptoms and pancreatic exocrine insufficiency in type 1 and 2 diabetes. Practical Diabetes. 2015. Vol. 32. P. 54–58.
15. Czako L., Hegyi P., Rakonczay Jr. Z., Wittmann T., Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009. Vol. 9. P. 351–359.
16. Dominguez Munoz J. E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin. Gastroenterol. Hepatol. 2007. Vol. 5. P. 484–488.
17. Domínguez-Munoz J. E. Pancreatic exocrine insufficiency: diagnosis and treatment. J. Gastroenterol. Hepatol. 2011. Vol. 26, No 2. P. 12–16.
18. Domínguez-Munoz J. E., Hardt P. D., Lerch M. M., Lohr M. J. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig. Dis. Sci. 2017. Vol. 62, No 5. P. 1119–1130.
19. Dominguez-Munoz J. E., Hieronymus C., Sauerbruch T., Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am. J. Gastroenterol. 1995. Vol. 90. P. 1834–1837.
20. Dominguez-Munoz J. E., Nieto L., Vilarino M., Lourido M. V., Iglesias-García J. Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas. 2016. Vol. 45, No 2. P. 241–247.
21. Dujsikova H., Dite P., Tomandl J., Sevcikova A., Precechtelova M. Occurrence of metabolic osteopathy in patients with chronic pancreatitis. Pancreatology. 2008. Vol. 8. P. 583–586.
22. Dutta S. K., Procaccino F., Aamodt R. Zinc metabolism in patients with exocrine pancreatic insufficiency. J. Am. Coll. Nutr. 1998. Vol. 17. P. 556–563.
23. Ebert R., Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenicsteatorrhea following enzyme substitution. Diabetologia. 1980. Vol. 19, No 3. P. 198–204.
24. el Newihi H., Dooley C. P., Saad C., Staples J., Zeidler A., Valenzuela J. E. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig. Dis. Sci. 1988. Vol. 33, No 6. P. 705–710.
25. Ewald N., Bretzel R. G., Fantus I. G., Hollenhorst M., Kloer H. U., Hardt P. D. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metabol. Res. Rev. 2007. Vol. 23, No 5. P. 386–391.
26. Ewald N., Raspe A., Kaufmann C., Bretzel R. G., Kloer H. U., Hardt P. D. Determinants of exocrine pancreatic function as measured by fecal elastase-1 concentrations (FEC) in patients with diabetes mellitus. Eur. J. Med. Res. 2009. Vol. 14, No 3. P. 118–122.
27. Foulis A. K., McGill M., Farquharson M. A., Hilton D. A. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 1997. Vol. 40, No 1. P. 53–61.
28. Frier B. M., Saunders J. H. B., Wormsley K. G., Bouchier I. A. D. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut. 1976. Vol. 17. P. 685–691.
29. Gamble D. R., Taylor K. W. Coxsackie B virus and diabetes. Br. Med. J. 1973. Vol. 3, No 1. P. 289–290.
30. Gilbeau J. P., Poncelet V., Libon E., Derue G., Heller F. R. The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients. AJR Am. J. Roentgenol. 1992. Vol. 159, No 3. P. 527–531.
31. Girish B. N., Rajesh G., Vaidyanathan K., Balakrishnan V. Zinc status in chronic pancreatitis and its relationship with exocrine and endocrine insufficiency. JOP. 2009. Vol. 10. P. 651–656.
32. Glasbrenner B., Malfertheiner P., Buchler M., Kuhn K., Ditschuneit H. Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder? Klin. Wochenschr. 1991. Vol. 69. P. 168–172.
33. Goda K., Sasaki E., Nagata K., Fukai M., Ohsawa N., Hahafusa T. Pancreatic volume in type 1 and type 2 diabetes mellitus. ActaDiabetol. 2001. Vol. 38. P. 145–149.
34. Gonzalez-Sanchez V., Amrani R., Gonzalez V., Trigo C., Pico A., de-Madaria E. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-mixed triglyceride breath test versus fecal elastase. Pancreatology. 2017. Vol. 17, No 4. P. 580–585.
35. Gustafsson R. J. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev. Diabet. Stud. 2011. Vol. 8. P. 268–275.
36. Haas S., Krins S., Knauerhase A., Lohr M. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP. 2015. Vol. 16, No 1. P. 58–62.
37. Hahn J. U., Kerner W., Maisonneuve P., Lowenfels A. B., Lankisch P. G. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008. Vol. 36. P. 274–278.
38. Harano Y., Kim C. I., Kang M., Shichiri M., Shimizu Y., Li H., et al. External pancreatic dysfunction associated with diabetes mellitus. J. Lab. Clin. Med. 1978. Vol. 91. P. 780–790.
39. Hardt P. D., Brendel M. D., Kloer H. U., Bretzel R. G. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008. Vol. 31. P. 165–169.
40. Hardt P. D., Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp. Diabetes. Res. 2011. Vol. 2011. P. 761950.
41. Hardt P. D., Hauenschild A., Jaeger C., Teichmann J., Bretzel R. G., Kloer H. U., et al. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig. Dis. Sci. 2003. Vol. 48. P. 1688–1692.
42. Hardt P. D., Hauenschild A., Nalop A., Marzeion A. M., Jaeger C., Teichmann J., et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology. 2003. Vol. 3, No 5. P. 395–402.
43. Hardt P. D., Killinger A., Nalop J., Schnell-Kretschmer H., Zekorn T., Klor H. U. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology. 2002. Vol. 2, No 1. P. 30–33.
44. Hardt P. D., Kloer H. U. Diabetes mellitus and exocrine pancreatic disease. Pancreatic Disease. 1998. Vol. 2. P. 235–241.
45. Hardt P. D., Krauss A., Bretz L., Porsch-Ozcürümez M., Schnell-Kretschmer H., Maser E., et al. Pancreatic exocrine function in patients with type-1 and type- 2 diabetes mellitus. ActaDiabetol. 2000. Vol. 37, No 3. P. 105–110.
46. Hardt P. D., Marzeion A. M., Schnell-Kretschmer H., Wüsten O., Nalop J., Zekorn T., et al. Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas. 2002. Vol. 25. P. 6–9.
47. Hartmann D., Felix K., Ehmann M., et al. Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis. Pancreas. 2007. Vol. 35, No 4. P. 334–342.
48. Icks A., Haastert B., Giani G., Rathmann W. Low fecal elastase-1 in type I diabetes mellitus. Zeitschrift fur Gastroenterologie. 2001. Vol. 39, No 10. P. 823–830.
49. Jackuliak P., Payer J. Osteoporosis, fractures, and diabetes. Internet J. Endocrinol. 2014. P. 820615.
50. Johnson E. J., Krasinski S. D., Howard L. J., Alger S. A., Dutta S. K., Russell R. M. Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am. J. Clin. Nutr. 1992. Vol. 55. P. 857–864.
51. Kangrga R. N., Ignjatovic S. D., Dragasevic M. M., Jovicic S. Z., Majkic-Singh N. T. Pancreatic elastase levels in feces as a marker of exocrine pancreatic function in patients with diabetes mellitus. Lab Med. 2016. Vol. 47, No 2. P. 140–148.
52. Kloppel G., Clemens A. Insulin-dependent diabetes mellitus. Current aspects of morphology, etiology and pathogenesis. Pathologe. 1996. Vol. 17, No 4. P. 269–275.
53. Kobayashi T., Nakanishi K., Kajio H., Morinaga S., Sugimoto T., Murase T., et al. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990. Vol. 33, No 6. P. 363–367.
54. Koch C. A., Uwaifo G. I. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur. J. Gastroenterol. Hepatol. 2008. Vol. 20, No 9. P. 822–825.
55. Krishnan B., Babu S., Walker J., Walker A. B., Pappachan J. M. Gastrointestinal complications of diabetes mellitus. World J. Diabetes. 2013. Vol. 4, No 3. P. 51– 63.
56. Lam W. F., Gielkens H. A., Coenraad M., Souverijn J. H., Lamers C. B., Masclee A. A. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans. Pancreas. 1999. Vol. 18. P. 252–258.
57. Lankisch P. G., Manthey G., Otto J., Talaulicar M., Willms B., Creutzfeldt W. Exocrine pancreatic function in insulin dependent diabetes mellitus. Digestion. 1982. Vol. 25. P. 210–216.
58. Larger E., Philippe M. F., Barbot-Trystram L., Radu A., Rotariu M., Nobecourt E., et al. Pancreatic exocrine function in patients with diabetes. Diabet. Med. 2012. Vol. 29. P. 1047–1054.
59. Leeds J. S., Oppong K., Sanders D. S. The role of fecal elastase 1 in detecting exocrine pancreatic disease. Nat. Rev. Gastroenterol. Hepatol. 2011. Vol. 8. P. 405–415.
60. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J. Gastroenterol. 2013. Vol. 19, No 42. P. 7258–7266.
61. Lindkvist B., Domínguez-Munoz J. E., Luaces-Regueira M., Castineiras-Alvarino M., Nieto-Garcia L., Iglesias-Garcia J. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012. Vol. 12. P. 305–310.
62. Lohr J. M., Oliver M. R., Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterol. J. 2013. Vol. 1, No 2. P. 79–83.
63. Lohr M., Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987. Vol. 30. P. 757–762.
64. Loser C., Mollgaard A., Folsch U. R. Faecalelastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996. Vol. 39. P. 580–586.
65. Lüth S., Teyssen S., Forssmann K., Kolbel C., Krummenauer F., Singer M. V. Fecal elastase-1 determination: ‘gold standard’ of indirect pancreatic function tests? Scand. J. Gastroenterol. 2001. Vol. 36, No 10. P. 1092–1099.
66. Martínez J., Laveda R., Trigo C., Frasquet J., Palazon J. M., Perez-Mateo M. Fecal elastase-1 determination in the diagnosis of chronic pancreatitis. Gastroenterol. Hepatol. 2002. Vol. 25, No 6. P. 377–382.
67. Mohan V., Poongothai S., Pitchumoni C. S. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int. J. Pancreatol. 1998. Vol. 24, No 1. P. 19–22.
68. Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L. A. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015. Vol. 4. P. 1. URL: https://doi.org/10.1186/2046-4053-4-1 (last accessed: 18.10.2018).
69. Nakamura T., Takebe K., Imamura K., Tando Y., Yamada N., Arai Y., et al. Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). ActaGastroenterol. Belg. 1996. Vol. 59. P. 10–14.
70. Nakanishi K., Kobayashi T., Miyashita H., Okubo M., Sugimoto T., Murase T., et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am. J. Gastroenterol. 1994. Vol. 89, No 5. P. 762–766.
71. Newihi E. H., Dooley C. P., Saad C., Staples J., Zeidler A., Valenzuela J. E. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig. Dis. Sci. 1988. Vol. 33, No 6. P. 705–710.
72. Nomiyama Y., Tashiro M., Yamaguchi T., Watanabe S., Taguchi M., Asaumi H., et al. High glucose activates rat pancreatic stellate cells through protein kinase C and p38 mitogen-activated protein kinase pathway. Pancreas. 2007. Vol. 3. P. 364–372.
73. Nunes A. C., Pontes J. M., Rosa A., Gomes L., Carvalheiro M., Freitas D. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus. Am. J. Gastroenterol. 2003. Vol. 98, No 12. P. 2672–2675.
74. O’Keefe S. J., Cariem A. K., Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J. Clin. Gastroenterol. 2001. Vol. 32, No 4. P. 319–323.
75. Oscarsson J., Nilsson C. A., Kvarnstrom M., Lindkvist B. Type 2 diabetes and pancreatic exocrine function: associations between fecal elastase-1 levels and gastrointestinal symptoms, plasma nutritional markers, and uptake of free versus esterified omega-3 fatty acids in a randomized, open-label, crossover study. Gastroenterology. 2017. Vol. 152, No 5. Suppl. 1. P. 899.
76. Patel R., Atherton P., Wackerhage H., Singh J. Signaling proteins associated with diabetic-induced exocrine pancreatic insufficiency in rats. Ann. NY Acad. Sci. 2006. Vol. 1084. P. 490–502.
77. Philippe M. F., Benabadji S., Barbot-Trystram L., Vadrot D., Boitard C., Larger E. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011. Vol. 40. P. 359–363.
78. Pollard H. M., Miller L., Brewer W. A. External secretion of the pancreas and diabetes. Am. J. Dig. Dis. 1943. Vol. 10, No 1. P. 20–23.
79. Putzke H. P., Friedrich G. Pancreatopathy in diabetes mellitus. Zentralbl. Allg. Pathol. 1986. Vol. 131, No 1. P. 37–41.
80. Raeder H., Johansson S., Holm P. I., Haldorsen I. S., Mas E., Sbarra V., et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006. Vol. 38(1). P. 54e62.
81. Rathmann W., Haastert B., Glasbrenner B. J., Berglind N., Nicholas J., Wareham N. J. Inverse association of HbA1c with faecalelastase 1 in people without diabetes. Pancreatology. 2015. Vol. 15, No 6. P. 620–625.
82. Rathmann W., Haastert B., Icks A., Giani G., Hennings S., Mitchell J., et al. Low fecal elastase 1 concentrations in type 2 diabetes. Scand. J. Gastroenterol. 2001. Vol. 36. P. 1056–1061.
83. Shivaprasad C, Pulikkal A. A., Kumar K. M. Pancreatic exocrine insufficiency in type 1 and type 2 diabetics of Indian origin. Pancreatology. 2015. Vol. 15, No 6. P. 616–619.
84. Sikkens E. C., Cahen D. L., Koch A. D., Braat H., Poley J. W., Kuipers E. J., Bruno M. J. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013. Vol. 13, No 3. P. 238–242.
85. Sikkens E. C., Cahen D. L., van Eijck C., Kuipers E. J., Bruno M. J. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. Pancreatology. 2012. Vol. 12, No 1. P. 71–73.
86. Struyvenberg M. R., Martin C. R., Freedman S. D. Practical guide to exocrine pancreatic insufficiency — breaking the myths. BMC Med. 2017. Vol. 15, No 1. P. 29.
87. Teichmann J., Lange U., Hardt P. Decreased pancreatic elastase 1 content: an independent risk factor of the osteoporosis in elderly women. Bone. 2001. Vol. 28. P. S194.
88. Teichmann J., Mann S. T.,Stracke H., Lange U., Hardt P. D., Klor H. U., et al. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur. J. Med. Res. 2007. Vol. 12. P. 347–350.
89. Teichmann J., Riemann J. F., Lange U. Prevalence of exocrine pancreatic insufficiency in women with obesity syndrome: assessment by pancreatic fecal elastase 1. ISRN Gastroenterol. 2011. P. 951686.
90. Terzin V., Varkonyi T., Szabolcs A., Lengyel C., Takacs T., Zsori G., et al. Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control. Pancreatology. 2014. Vol. 14, No 5. P. 356–360.
91. Thorat V., Reddy N., Bhatia S., Bapaye A., Rajkumar J. S., Kini D. D., et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40 000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis — a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 2012. Vol. 36. P. 426–436.
92. Tignor A. S., Wu B. U., Whitlock T. L., Lopez R., Repas K., Banks P. A., et al. High prevalence of low-trauma fracture in chronic pancreatitis. Am. J. Gastroenterol. 2010. Vol. 105, No 12. P. 2680–2686.
93. Vacca J. B., Henke W. J., Knight W. A. The exocrine pancreas in diabetes mellitus. Ann. Intern. Med. 1964. Vol. 61. P. 242–247.
94. Vujasinovic M., Zaletel J., Tepes B., Popic B., Makuc J., Epsek L. M., et al. Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus. Pancreatology. 2013. Vol. 13. P. 343–346.
95. Whitcomb D. C., Bodhani A., Beckmann K., Sander-Struckmeier S., Liu S., Fuldeore M., et al. Efficacy and safety of pancrelipase/pancreatin in patients with exocrine pancreatic insufficiency and a medical history of diabetes mellitus. Pancreas. 2016. Vol. 45, No 5. P. 679–686.
96. Williams A. J., Chau W., Callaway M. P., et al. Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabet. Med. 2007. Vol. 24. P. 35–40.
97. Williams A. J., Thrower S. L., Sequeiros I. M., et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 2012. Vol. 97. P. 2109–2113.
98. Working Party of the Australasian Pancreatic Club, Smith R. C., Smith S. F., Wilson J., Pearce C., Wray N., et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016. Vol. 16, No 2. P. 164–180.
99. Yilmaztepe A., Ulukaya E., Ersoy C., Yilmaz M., Tokullugil H. A. Investigation of fecal pancreatic elastase-1 levels in type 2 diabetic patients. Turk. J. Gastroenterol. 2005. Vol. 16, No 2. P. 75–80.
2. Alzaid A., Aideyan O., Nawaz S. The size of the pancreas in diabetes mellitus. Diabet. Med. 1993. Vol. 10, No 8. P. 759–763.
3. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017. Vol. 40, No 1. P. 11– 24.
4. Barreto S. G., Carati C. J., Toouli J., et al. The islet-acinar axis of the pancreas: more than just insulin. Am. J. Physiol. Gastrointest. Liver Physiol. 2010. Vol. 299, No 1. P. 10–22.
5. Berry A. J. Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr. Clin. Pract. 2014. Vol. 29. P. 312–321.
6. Bilgin M., Balci N. C., Momtahen A. J., Bilgin Y., Klor H. U., Rau W. S. MRI and MRCP findings of the pancreas pancreatic exocrine function determined by fecal elastase 1. J. Clin. Gastroenterol. 2009. Vol. 43, No 2. P. 165–170.
7. Blumenthal H. T., Probstein J. G., Berns A. W. Interrelationship of diabetes mellitus and pancreatitis. Arch. Surg. 1963. Vol. 87. P. 844–850.
8. Bresnahan K. A., Tanumihardjo S. A. Undernutrition, the acute phase response to infection, and its effects on micronutrient status indicators. Adv. Nutr. 2014. Vol. 5, No 6. P. 702–711.
9. Bretzke G. Diabetes mellitus und exocrine pancreas function. Zeitschriftfur dieGesamteInnereMedizin und IhreGrenzgebiete. 1984. Vol. 39, No 16. P. 388–390.
10. Burute N., Nisenbaum R., Jenkins D. J., Mirrahimi A., Anthwal S., Colak E., et al. Pancreas volume measurement in patients with type 2 diabetes using magnetic resonance imaging-based planimetry. Pancreatology. 2014. Vol. 14, No 4. P. 268–274.
11. Cavalot F., Bonomo K., Perna P., Bacillo E., Salacone P., Gallo M., et al. Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual ß-cell secretion and metabolic control in type 1 diabetic subjects. Diabetes Care. 2004. Vol. 27, No 8. P. 2052–2054.
12. Chey W. Y., Shay H., Shuman C. R. External pancreatic secretion in diabetes mellitus. Ann. Intern. Med. 1953. Vol. 59. P. 812–821.
13. Creutzfeldt W., Gleichmann D., Otto J, Stockmann F., Maisonneuve P., Lankisch P. G. Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion. 2005. Vol. 72. P. 71–75.
14. Cummings M. H, Chong L., Hunter V., Kar P. S., Meeking D. R., Cranston I. C. Gastrointestinal symptoms and pancreatic exocrine insufficiency in type 1 and 2 diabetes. Practical Diabetes. 2015. Vol. 32. P. 54–58.
15. Czako L., Hegyi P., Rakonczay Jr. Z., Wittmann T., Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009. Vol. 9. P. 351–359.
16. Dominguez Munoz J. E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin. Gastroenterol. Hepatol. 2007. Vol. 5. P. 484–488.
17. Domínguez-Munoz J. E. Pancreatic exocrine insufficiency: diagnosis and treatment. J. Gastroenterol. Hepatol. 2011. Vol. 26, No 2. P. 12–16.
18. Domínguez-Munoz J. E., Hardt P. D., Lerch M. M., Lohr M. J. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig. Dis. Sci. 2017. Vol. 62, No 5. P. 1119–1130.
19. Dominguez-Munoz J. E., Hieronymus C., Sauerbruch T., Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am. J. Gastroenterol. 1995. Vol. 90. P. 1834–1837.
20. Dominguez-Munoz J. E., Nieto L., Vilarino M., Lourido M. V., Iglesias-García J. Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pancreas. 2016. Vol. 45, No 2. P. 241–247.
21. Dujsikova H., Dite P., Tomandl J., Sevcikova A., Precechtelova M. Occurrence of metabolic osteopathy in patients with chronic pancreatitis. Pancreatology. 2008. Vol. 8. P. 583–586.
22. Dutta S. K., Procaccino F., Aamodt R. Zinc metabolism in patients with exocrine pancreatic insufficiency. J. Am. Coll. Nutr. 1998. Vol. 17. P. 556–563.
23. Ebert R., Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenicsteatorrhea following enzyme substitution. Diabetologia. 1980. Vol. 19, No 3. P. 198–204.
24. el Newihi H., Dooley C. P., Saad C., Staples J., Zeidler A., Valenzuela J. E. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig. Dis. Sci. 1988. Vol. 33, No 6. P. 705–710.
25. Ewald N., Bretzel R. G., Fantus I. G., Hollenhorst M., Kloer H. U., Hardt P. D. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metabol. Res. Rev. 2007. Vol. 23, No 5. P. 386–391.
26. Ewald N., Raspe A., Kaufmann C., Bretzel R. G., Kloer H. U., Hardt P. D. Determinants of exocrine pancreatic function as measured by fecal elastase-1 concentrations (FEC) in patients with diabetes mellitus. Eur. J. Med. Res. 2009. Vol. 14, No 3. P. 118–122.
27. Foulis A. K., McGill M., Farquharson M. A., Hilton D. A. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 1997. Vol. 40, No 1. P. 53–61.
28. Frier B. M., Saunders J. H. B., Wormsley K. G., Bouchier I. A. D. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut. 1976. Vol. 17. P. 685–691.
29. Gamble D. R., Taylor K. W. Coxsackie B virus and diabetes. Br. Med. J. 1973. Vol. 3, No 1. P. 289–290.
30. Gilbeau J. P., Poncelet V., Libon E., Derue G., Heller F. R. The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients. AJR Am. J. Roentgenol. 1992. Vol. 159, No 3. P. 527–531.
31. Girish B. N., Rajesh G., Vaidyanathan K., Balakrishnan V. Zinc status in chronic pancreatitis and its relationship with exocrine and endocrine insufficiency. JOP. 2009. Vol. 10. P. 651–656.
32. Glasbrenner B., Malfertheiner P., Buchler M., Kuhn K., Ditschuneit H. Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder? Klin. Wochenschr. 1991. Vol. 69. P. 168–172.
33. Goda K., Sasaki E., Nagata K., Fukai M., Ohsawa N., Hahafusa T. Pancreatic volume in type 1 and type 2 diabetes mellitus. ActaDiabetol. 2001. Vol. 38. P. 145–149.
34. Gonzalez-Sanchez V., Amrani R., Gonzalez V., Trigo C., Pico A., de-Madaria E. Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-mixed triglyceride breath test versus fecal elastase. Pancreatology. 2017. Vol. 17, No 4. P. 580–585.
35. Gustafsson R. J. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev. Diabet. Stud. 2011. Vol. 8. P. 268–275.
36. Haas S., Krins S., Knauerhase A., Lohr M. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP. 2015. Vol. 16, No 1. P. 58–62.
37. Hahn J. U., Kerner W., Maisonneuve P., Lowenfels A. B., Lankisch P. G. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas. 2008. Vol. 36. P. 274–278.
38. Harano Y., Kim C. I., Kang M., Shichiri M., Shimizu Y., Li H., et al. External pancreatic dysfunction associated with diabetes mellitus. J. Lab. Clin. Med. 1978. Vol. 91. P. 780–790.
39. Hardt P. D., Brendel M. D., Kloer H. U., Bretzel R. G. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008. Vol. 31. P. 165–169.
40. Hardt P. D., Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp. Diabetes. Res. 2011. Vol. 2011. P. 761950.
41. Hardt P. D., Hauenschild A., Jaeger C., Teichmann J., Bretzel R. G., Kloer H. U., et al. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig. Dis. Sci. 2003. Vol. 48. P. 1688–1692.
42. Hardt P. D., Hauenschild A., Nalop A., Marzeion A. M., Jaeger C., Teichmann J., et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology. 2003. Vol. 3, No 5. P. 395–402.
43. Hardt P. D., Killinger A., Nalop J., Schnell-Kretschmer H., Zekorn T., Klor H. U. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology. 2002. Vol. 2, No 1. P. 30–33.
44. Hardt P. D., Kloer H. U. Diabetes mellitus and exocrine pancreatic disease. Pancreatic Disease. 1998. Vol. 2. P. 235–241.
45. Hardt P. D., Krauss A., Bretz L., Porsch-Ozcürümez M., Schnell-Kretschmer H., Maser E., et al. Pancreatic exocrine function in patients with type-1 and type- 2 diabetes mellitus. ActaDiabetol. 2000. Vol. 37, No 3. P. 105–110.
46. Hardt P. D., Marzeion A. M., Schnell-Kretschmer H., Wüsten O., Nalop J., Zekorn T., et al. Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas. 2002. Vol. 25. P. 6–9.
47. Hartmann D., Felix K., Ehmann M., et al. Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis. Pancreas. 2007. Vol. 35, No 4. P. 334–342.
48. Icks A., Haastert B., Giani G., Rathmann W. Low fecal elastase-1 in type I diabetes mellitus. Zeitschrift fur Gastroenterologie. 2001. Vol. 39, No 10. P. 823–830.
49. Jackuliak P., Payer J. Osteoporosis, fractures, and diabetes. Internet J. Endocrinol. 2014. P. 820615.
50. Johnson E. J., Krasinski S. D., Howard L. J., Alger S. A., Dutta S. K., Russell R. M. Evaluation of vitamin A absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and in patients with gastrointestinal disease. Am. J. Clin. Nutr. 1992. Vol. 55. P. 857–864.
51. Kangrga R. N., Ignjatovic S. D., Dragasevic M. M., Jovicic S. Z., Majkic-Singh N. T. Pancreatic elastase levels in feces as a marker of exocrine pancreatic function in patients with diabetes mellitus. Lab Med. 2016. Vol. 47, No 2. P. 140–148.
52. Kloppel G., Clemens A. Insulin-dependent diabetes mellitus. Current aspects of morphology, etiology and pathogenesis. Pathologe. 1996. Vol. 17, No 4. P. 269–275.
53. Kobayashi T., Nakanishi K., Kajio H., Morinaga S., Sugimoto T., Murase T., et al. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990. Vol. 33, No 6. P. 363–367.
54. Koch C. A., Uwaifo G. I. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur. J. Gastroenterol. Hepatol. 2008. Vol. 20, No 9. P. 822–825.
55. Krishnan B., Babu S., Walker J., Walker A. B., Pappachan J. M. Gastrointestinal complications of diabetes mellitus. World J. Diabetes. 2013. Vol. 4, No 3. P. 51– 63.
56. Lam W. F., Gielkens H. A., Coenraad M., Souverijn J. H., Lamers C. B., Masclee A. A. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans. Pancreas. 1999. Vol. 18. P. 252–258.
57. Lankisch P. G., Manthey G., Otto J., Talaulicar M., Willms B., Creutzfeldt W. Exocrine pancreatic function in insulin dependent diabetes mellitus. Digestion. 1982. Vol. 25. P. 210–216.
58. Larger E., Philippe M. F., Barbot-Trystram L., Radu A., Rotariu M., Nobecourt E., et al. Pancreatic exocrine function in patients with diabetes. Diabet. Med. 2012. Vol. 29. P. 1047–1054.
59. Leeds J. S., Oppong K., Sanders D. S. The role of fecal elastase 1 in detecting exocrine pancreatic disease. Nat. Rev. Gastroenterol. Hepatol. 2011. Vol. 8. P. 405–415.
60. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J. Gastroenterol. 2013. Vol. 19, No 42. P. 7258–7266.
61. Lindkvist B., Domínguez-Munoz J. E., Luaces-Regueira M., Castineiras-Alvarino M., Nieto-Garcia L., Iglesias-Garcia J. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012. Vol. 12. P. 305–310.
62. Lohr J. M., Oliver M. R., Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterol. J. 2013. Vol. 1, No 2. P. 79–83.
63. Lohr M., Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987. Vol. 30. P. 757–762.
64. Loser C., Mollgaard A., Folsch U. R. Faecalelastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996. Vol. 39. P. 580–586.
65. Lüth S., Teyssen S., Forssmann K., Kolbel C., Krummenauer F., Singer M. V. Fecal elastase-1 determination: ‘gold standard’ of indirect pancreatic function tests? Scand. J. Gastroenterol. 2001. Vol. 36, No 10. P. 1092–1099.
66. Martínez J., Laveda R., Trigo C., Frasquet J., Palazon J. M., Perez-Mateo M. Fecal elastase-1 determination in the diagnosis of chronic pancreatitis. Gastroenterol. Hepatol. 2002. Vol. 25, No 6. P. 377–382.
67. Mohan V., Poongothai S., Pitchumoni C. S. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int. J. Pancreatol. 1998. Vol. 24, No 1. P. 19–22.
68. Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., Shekelle P., Stewart L. A. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015. Vol. 4. P. 1. URL: https://doi.org/10.1186/2046-4053-4-1 (last accessed: 18.10.2018).
69. Nakamura T., Takebe K., Imamura K., Tando Y., Yamada N., Arai Y., et al. Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). ActaGastroenterol. Belg. 1996. Vol. 59. P. 10–14.
70. Nakanishi K., Kobayashi T., Miyashita H., Okubo M., Sugimoto T., Murase T., et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am. J. Gastroenterol. 1994. Vol. 89, No 5. P. 762–766.
71. Newihi E. H., Dooley C. P., Saad C., Staples J., Zeidler A., Valenzuela J. E. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig. Dis. Sci. 1988. Vol. 33, No 6. P. 705–710.
72. Nomiyama Y., Tashiro M., Yamaguchi T., Watanabe S., Taguchi M., Asaumi H., et al. High glucose activates rat pancreatic stellate cells through protein kinase C and p38 mitogen-activated protein kinase pathway. Pancreas. 2007. Vol. 3. P. 364–372.
73. Nunes A. C., Pontes J. M., Rosa A., Gomes L., Carvalheiro M., Freitas D. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus. Am. J. Gastroenterol. 2003. Vol. 98, No 12. P. 2672–2675.
74. O’Keefe S. J., Cariem A. K., Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J. Clin. Gastroenterol. 2001. Vol. 32, No 4. P. 319–323.
75. Oscarsson J., Nilsson C. A., Kvarnstrom M., Lindkvist B. Type 2 diabetes and pancreatic exocrine function: associations between fecal elastase-1 levels and gastrointestinal symptoms, plasma nutritional markers, and uptake of free versus esterified omega-3 fatty acids in a randomized, open-label, crossover study. Gastroenterology. 2017. Vol. 152, No 5. Suppl. 1. P. 899.
76. Patel R., Atherton P., Wackerhage H., Singh J. Signaling proteins associated with diabetic-induced exocrine pancreatic insufficiency in rats. Ann. NY Acad. Sci. 2006. Vol. 1084. P. 490–502.
77. Philippe M. F., Benabadji S., Barbot-Trystram L., Vadrot D., Boitard C., Larger E. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011. Vol. 40. P. 359–363.
78. Pollard H. M., Miller L., Brewer W. A. External secretion of the pancreas and diabetes. Am. J. Dig. Dis. 1943. Vol. 10, No 1. P. 20–23.
79. Putzke H. P., Friedrich G. Pancreatopathy in diabetes mellitus. Zentralbl. Allg. Pathol. 1986. Vol. 131, No 1. P. 37–41.
80. Raeder H., Johansson S., Holm P. I., Haldorsen I. S., Mas E., Sbarra V., et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006. Vol. 38(1). P. 54e62.
81. Rathmann W., Haastert B., Glasbrenner B. J., Berglind N., Nicholas J., Wareham N. J. Inverse association of HbA1c with faecalelastase 1 in people without diabetes. Pancreatology. 2015. Vol. 15, No 6. P. 620–625.
82. Rathmann W., Haastert B., Icks A., Giani G., Hennings S., Mitchell J., et al. Low fecal elastase 1 concentrations in type 2 diabetes. Scand. J. Gastroenterol. 2001. Vol. 36. P. 1056–1061.
83. Shivaprasad C, Pulikkal A. A., Kumar K. M. Pancreatic exocrine insufficiency in type 1 and type 2 diabetics of Indian origin. Pancreatology. 2015. Vol. 15, No 6. P. 616–619.
84. Sikkens E. C., Cahen D. L., Koch A. D., Braat H., Poley J. W., Kuipers E. J., Bruno M. J. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013. Vol. 13, No 3. P. 238–242.
85. Sikkens E. C., Cahen D. L., van Eijck C., Kuipers E. J., Bruno M. J. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. Pancreatology. 2012. Vol. 12, No 1. P. 71–73.
86. Struyvenberg M. R., Martin C. R., Freedman S. D. Practical guide to exocrine pancreatic insufficiency — breaking the myths. BMC Med. 2017. Vol. 15, No 1. P. 29.
87. Teichmann J., Lange U., Hardt P. Decreased pancreatic elastase 1 content: an independent risk factor of the osteoporosis in elderly women. Bone. 2001. Vol. 28. P. S194.
88. Teichmann J., Mann S. T.,Stracke H., Lange U., Hardt P. D., Klor H. U., et al. Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis. Eur. J. Med. Res. 2007. Vol. 12. P. 347–350.
89. Teichmann J., Riemann J. F., Lange U. Prevalence of exocrine pancreatic insufficiency in women with obesity syndrome: assessment by pancreatic fecal elastase 1. ISRN Gastroenterol. 2011. P. 951686.
90. Terzin V., Varkonyi T., Szabolcs A., Lengyel C., Takacs T., Zsori G., et al. Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control. Pancreatology. 2014. Vol. 14, No 5. P. 356–360.
91. Thorat V., Reddy N., Bhatia S., Bapaye A., Rajkumar J. S., Kini D. D., et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40 000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis — a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 2012. Vol. 36. P. 426–436.
92. Tignor A. S., Wu B. U., Whitlock T. L., Lopez R., Repas K., Banks P. A., et al. High prevalence of low-trauma fracture in chronic pancreatitis. Am. J. Gastroenterol. 2010. Vol. 105, No 12. P. 2680–2686.
93. Vacca J. B., Henke W. J., Knight W. A. The exocrine pancreas in diabetes mellitus. Ann. Intern. Med. 1964. Vol. 61. P. 242–247.
94. Vujasinovic M., Zaletel J., Tepes B., Popic B., Makuc J., Epsek L. M., et al. Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus. Pancreatology. 2013. Vol. 13. P. 343–346.
95. Whitcomb D. C., Bodhani A., Beckmann K., Sander-Struckmeier S., Liu S., Fuldeore M., et al. Efficacy and safety of pancrelipase/pancreatin in patients with exocrine pancreatic insufficiency and a medical history of diabetes mellitus. Pancreas. 2016. Vol. 45, No 5. P. 679–686.
96. Williams A. J., Chau W., Callaway M. P., et al. Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabet. Med. 2007. Vol. 24. P. 35–40.
97. Williams A. J., Thrower S. L., Sequeiros I. M., et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 2012. Vol. 97. P. 2109–2113.
98. Working Party of the Australasian Pancreatic Club, Smith R. C., Smith S. F., Wilson J., Pearce C., Wray N., et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016. Vol. 16, No 2. P. 164–180.
99. Yilmaztepe A., Ulukaya E., Ersoy C., Yilmaz M., Tokullugil H. A. Investigation of fecal pancreatic elastase-1 levels in type 2 diabetic patients. Turk. J. Gastroenterol. 2005. Vol. 16, No 2. P. 75–80.